BTK.md
... ...
@@ -20,8 +20,8 @@ timeline
20 20
21 21
|Entity|Tier|Description |
22 22
|:------:|:----:|--------------------------|
23
-|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene[@albuquerqueEnhancingKnowledgeDiscovery2017a; @reddyGeneticFunctionalDrivers2017]|
24
-|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene [@krysiakRecurrentSomaticMutations2017b]|
23
+|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene[@albuquerqueEnhancingKnowledgeDiscovery2017; @reddyGeneticFunctionalDrivers2017]|
24
+|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene [@krysiakRecurrentSomaticMutations2017]|
25 25
26 26
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
27 27
EBF1.md
... ...
@@ -29,8 +29,8 @@ timeline
29 29
30 30
|Entity|Tier|Description |
31 31
|:------:|:----:|--------------------------------------|
32
-|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene[@reichelFlowSortingExome2015a]|
33
-|![DLBCL](images/icons/DLBCL_tier1.png) |1-a | aSHM target and high-confidence DLBCL gene [@bohleRoleEarlyBcell2013; @albuquerqueEnhancingKnowledgeDiscovery2017a; @morinMutationalStructuralAnalysis2013]|
32
+|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene[@reichelFlowSortingExome2015]|
33
+|![DLBCL](images/icons/DLBCL_tier1.png) |1-a | aSHM target and high-confidence DLBCL gene [@bohleRoleEarlyBcell2013; @albuquerqueEnhancingKnowledgeDiscovery2017; @morinMutationalStructuralAnalysis2013]|
34 34
|![FL](images/icons/FL_tier1.png) |1-a | aSHM target and high-confidence FL gene |
35 35
|![BL](images/icons/BL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in BL is tenuous [@thomasGeneticSubgroupsInform2023]|
36 36